Image

The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study

The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study

Not Recruiting
1 years and older
All
Phase N/A

Powered by AI

Overview

Fibromyalgia is a chronic and intricate musculoskeletal disorder characterized by widespread pain, fatigue, and tenderness in specific anatomical regions. Although its prevalence varies among populations, understanding the prevalence in different geographical areas is crucial for healthcare planning. This cross-sectional study aims to determine the prevalence of fibromyalgia in adults residing in Al-Karak, Jordan. The city's unique demographic and environmental characteristics may influence the occurrence of fibromyalgia among its adult population. The study aims to address gaps in knowledge, provide localized insights, and shed light on fibromyalgia's burden on the community's health. Accurate prevalence data aids healthcare planning and resource allocation.

Eligibility

Using google forms, this cross-sectional study was carried out, and the participants were

reached via social media platforms (5)

        . Participants' autonomy was maintained, and no direct benefit was gained in return for
        filling out the questionnaire. The ethics committee at the Faculty of Medicine, Mutah
        University, Karak, Jordan, provided the required ethical approval prior to the initiation
        of this study. Moreover, the committee ensured that the study was designed according to the
        principles of the Declaration of Helsinki (Date: 13 February 2023. Reference number:
        992023). In this study, the authors targeted Karak government citizens, in Jordan.
        Accordingly, the required sample size to achieve a 99% Confidence interval was 663
        participants.

Study details
    Fibromyalgia
    Orthopedic Disorder

NCT06103058

Mutah University

30 January 2026

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.